PharmaCyte Biotech Inc (PMCB) — Strategic Asset Allocation Index
PharmaCyte Biotech Inc (PMCB) has a Strategic Asset Allocation Index of 57.0% as of January 2026. Strategic assets (PP&E of $- plus long-term investments of $22.47 Million) total $22.47 Million, measured against net assets of $39.40 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check PharmaCyte Biotech Inc (PMCB) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
PharmaCyte Biotech Inc Strategic Asset Allocation Index (2006–2025)
This chart shows how PharmaCyte Biotech Inc's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2025. As of January 2026, the index stands at 57.0%, representing strategic assets of $22.47 Million against net assets of $39.40 Million USD. See financial flexibility index of PharmaCyte Biotech Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for PharmaCyte Biotech Inc (2006–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for PharmaCyte Biotech Inc from 2006 to 2025, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PharmaCyte Biotech Inc (PMCB) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.3% | $22.47 Million | $- | $22.47 Million | $51.89 Million | ▲ +43.3 pp |
| 2024 | 0.0% | $0.00 | $- | $0.00 | $39.51 Million | ▼ -2.2 pp |
| 2023 | 2.2% | $1.57 Million | $- | $1.57 Million | $72.69 Million | ▲ +0.4 pp |
| 2022 | 1.7% | $1.57 Million | $- | $1.57 Million | $89.92 Million | ▼ -21.8 pp |
| 2021 | 23.5% | $1.57 Million | $- | $1.57 Million | $6.68 Million | ▼ -7.4 pp |
| 2020 | 30.9% | $1.57 Million | $- | $1.57 Million | $5.09 Million | ▼ -0.3 pp |
| 2019 | 31.2% | $1.57 Million | $- | $1.57 Million | $5.04 Million | ▲ +3.9 pp |
| 2018 | 27.3% | $1.57 Million | $- | $1.57 Million | $5.77 Million | ▲ +7.8 pp |
| 2017 | 19.4% | $1.57 Million | $- | $1.57 Million | $8.09 Million | ▼ -4.7 pp |
| 2016 | 24.1% | $1.57 Million | $- | $1.57 Million | $6.52 Million | ▼ -2.4 pp |
| 2015 | 26.5% | $1.57 Million | $- | $1.57 Million | $5.94 Million | ▲ +8.9 pp |
| 2014 | 17.6% | $1.57 Million | $- | $1.57 Million | $8.94 Million | ▼ -48.7 pp |
| 2009 | 66.3% | $2.64 Million | $2.64 Million | $- | $3.99 Million | ▲ +66.0 pp |
| 2008 | 0.3% | $23.00K | $23.00K | $- | $7.44 Million | ▲ +0.1 pp |
| 2007 | 0.2% | $8.00K | $8.00K | $- | $4.29 Million | ▲ +0.0 pp |
| 2006 | 0.2% | $7.00K | $7.00K | $- | $4.41 Million | — |